- Home
- AMST vs NERV Comparison
AMST vs NERV Comparison
Compare AMST & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMST
- NERV
- Stock Information
- Founded
- AMST 2017
- NERV 2007
- Country
- AMST United States
- NERV United States
- Employees
- AMST N/A
- NERV N/A
- Industry
- AMST Computer Software: Prepackaged Software
- NERV Biotechnology: Pharmaceutical Preparations
- Sector
- AMST Technology
- NERV Health Care
- Exchange
- AMST Nasdaq
- NERV Nasdaq
- Market Cap
- AMST 14.0M
- NERV 14.6M
- IPO Year
- AMST 2020
- NERV 2014
- Fundamental
- Price
- AMST $3.52
- NERV $2.83
- Analyst Decision
- AMST
- NERV Hold
- Analyst Count
- AMST 0
- NERV 1
- Target Price
- AMST N/A
- NERV $5.00
- AVG Volume (30 Days)
- AMST 2.2M
- NERV 639.5K
- Earning Date
- AMST 11-13-2025
- NERV 11-04-2025
- Dividend Yield
- AMST N/A
- NERV N/A
- EPS Growth
- AMST N/A
- NERV N/A
- EPS
- AMST N/A
- NERV 1.48
- Revenue
- AMST $110,459.00
- NERV N/A
- Revenue This Year
- AMST N/A
- NERV N/A
- Revenue Next Year
- AMST N/A
- NERV N/A
- P/E Ratio
- AMST N/A
- NERV $1.47
- Revenue Growth
- AMST N/A
- NERV N/A
- 52 Week Low
- AMST $2.00
- NERV $1.15
- 52 Week High
- AMST $6.27
- NERV $3.29
- Technical
- Relative Strength Index (RSI)
- AMST 57.84
- NERV 70.41
- Support Level
- AMST $3.02
- NERV $2.06
- Resistance Level
- AMST $3.61
- NERV $2.15
- Average True Range (ATR)
- AMST 0.20
- NERV 0.11
- MACD
- AMST 0.02
- NERV 0.02
- Stochastic Oscillator
- AMST 67.42
- NERV 70.72
About AMST Amesite Inc.
Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high-performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are Enterprises, universities, and K-12 schools.
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.